XM does not provide services to residents of the United States of America.

Live Nation issued subpoena regarding ticketing, fees by US Senate panel

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Live Nation issued subpoena regarding ticketing, fees by US Senate panel</title></head><body>

Adds comment from Live Nation, background

WASHINGTON, Nov 20 (Reuters) -Live Nation LYV.N and its subsidiary Ticketmaster is being sent a subpoena for documents regarding ticket pricing, fees and secondary sales, a U.S. Senate panel said on Monday.

Ticketmaster, which for decades hasbeen criticized for hardball tactics and high prices, took a new round of rhetorical beatings aroundthis time last year after botched ticket sales for Taylor Swift's "Eras" tour.

"Live Nation has egregiously stonewalled my Subcommittee’s inquiry into its abusive consumer practices — making the subpoena necessary," Senator Richard Blumenthal, Democratic chairof the U.S. Senate Permanent Subcommittee on Investigations, said in a statement.

In a cover letter that accompanied the subpoena, Blumenthal said Live Nation had failed to fully comply with document requests sent in March. The letter was dated Nov 16.

A Live Nation spokesperson said the company had provided "extensive information" to the subcommittee and met with staff several times.

"In order to provide additional information requested about artist and client compensation and other similarly sensitive matters, we’ve asked for standard confidentiality measures. Thus far the Subcommittee has refused to provide such assurances, but if and when those protections are in place we will provide additional information on these issues," the spokesperson said.

The subpoena would require the company to turn over internal documents and communications related to ticket prices, annual financial data regarding fees, the ticket resale business as well as its relationship with artists and venues.

Reporting by Diane Bartz; Editing by Lisa Shumaker and David Gregorio


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.